Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

johnson & johnson medical pty ltd t/a depuy synthes - 45061 - fixation anchor, soft-tissue, biodegradable - the healix advance self punching biocomposite anchor is a sterile implant designed to secure soft tissue to bone when used in conjunction with suture. the two-piece, self-punching design consists of a cannulated, threaded anchor and cannulated dilator which are permanently implanted into the body. each device includes the resorbable anchor, a disposable inserter, and non-absorbable suture. the healix advance sp biocomposite anchor is indicated for use in the following procedures for reattachment of soft tissue to bone: shoulder: rotator cuff repair, deltoid repair

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

arthrex australia pty ltd - 45039 - fixation screw, bone, biodegradable - the fastthread biocomposite interference screw is comprised of plla or pldla, biphasic calcium phosphate. fast and easy insertion are attributed by the implants prominent thread pitch. the vented design reduces material implanted and allows bony ingrowth which promotes absorption. the screw provides the necessary pull-out strength during healing the fastthread biocomposite interference screw is intended to be used for fixation of tissue, including ligament or tendon to bone, or a bone/tendon to bone or soft tissue grafts during anterior cruciate ligament repair.

Singapur - İngilizce - HSA (Health Sciences Authority)

johnson & johnson pte ltd - orthopaedics - the healix advance sp biocomposite anchor is indicated for use in the following procedures for reattachment of soft tissue to bone: • shoulder: rotator cuff repair

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

zimmer biomet pty ltd - 45061 - fixation anchor, soft-tissue, biodegradable - this product is an absorbable bone fixation screw that fixes soft tissues such as ligament, tendon, and the articular capsules to a bone, and is used in orthopedic surgery. the implant screw is made of poly (l-lactide-co-glycolide) (plga) and tri-calciumphosphate (?-tcp). neo advance biocomposite acl screw is a fixation screw that fixes soft tissues such as ligaments, tendons, and the articular capsules to a bone, and is used in orthopedic surgery.

Malezya - İngilizce - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

luxor network sdn. bhd. - krill oil -

ABD - İngilizce - NLM (National Library of Medicine)

star pharmaceuticals llc - methenamine (unii: j50oix95qv) (methenamine - unii:j50oix95qv), sodium phosphate, monobasic, monohydrate (unii: 593yog76rn) (sodium cation - unii:lyr4m0nh37), phenyl salicylate (unii: 28a37t47qo) (phenyl salicylate - unii:28a37t47qo), methylene blue (unii: t42p99266k) (methylene blue cation - unii:zmz79891zh), hyoscyamine sulfate (unii: f2r8v82b84) (hyoscyamine - unii:px44xo846x) - methenamine 120 mg - ustell™ capsules are indicated for the treatment of symptoms of irritative voiding. indicated for the relief of local symptoms, such as inflammation, hypermotility, and pain, which accompany lower urinary tract infections. indicated for the relief of urinary tract symptoms caused by diagnostic procedures. hypersensitivity to any of the ingredients is possible. risk benefits should be carefully considered when the following medical problems exist: cardiac disease (especially cardiac arrhythmias, congestive heart failure, coronary heart disease, and mitral stenosis); gastrointestinal tract obstructive disease; glaucoma; myasthenia gravis, acute urinary retention may be precipitated in obstructive uropathy (such as bladder neck obstruction due to prostatic hypertrophy). a dependence on the use of ustell™ capsules has not been reported and due to the nature of its ingredients, abuse of ustell™ capsules is not expected.

ABD - İngilizce - NLM (National Library of Medicine)

star pharmaceuticals, llc - methenamine (unii: j50oix95qv) (methenamine - unii:j50oix95qv), benzoic acid (unii: 8skn0b0mim) (benzoic acid - unii:8skn0b0mim), phenyl salicylate (unii: 28a37t47qo) (phenyl salicylate - unii:28a37t47qo), methylene blue (unii: t42p99266k) (methylene blue cation - unii:zmz79891zh), hyoscyamine sulfate (unii: f2r8v82b84) (hyoscyamine - unii:px44xo846x) - methenamine 81.6 mg - hyophen ™ tablets are indicated for the treatment of symptoms of irritative voiding. indicated for the relief of local symptoms, such as inflammation, hypermotility, and pain, which accompany lower urinary tract infections. indicated for the relief of urinary tract symptoms caused by diagnostic procedures. hypersensitivity to any of the ingredients is possible. risk benefits should be carefully considered when the following medical problems exist: cardiac disease (especially cardiac arrhythmias, congestive heart failure, coronary heart disease, and mitral stenosis); gastrointestinal tract obstructive disease; glaucoma; myasthenia gravis, acute urinary retention may be precipitated in obstructive uropathy (such as bladder neck obstruction due to prostatic hypertrophy). a dependence on the use of hyophen ™ tablets has not been reported and due to the nature of its ingredients, abuse of hyophen ™ tablets is not expected.

ABD - İngilizce - NLM (National Library of Medicine)

star pharmaceuticals, llc - sodium phosphate, monobasic, monohydrate (unii: 593yog76rn) (sodium cation - unii:lyr4m0nh37), phenyl salicylate (unii: 28a37t47qo) (phenyl salicylate - unii:28a37t47qo), hyoscyamine sulfate (unii: f2r8v82b84) (hyoscyamine - unii:px44xo846x), methylene blue (unii: t42p99266k) (methylene blue cation - unii:zmz79891zh), methenamine (unii: j50oix95qv) (methenamine - unii:j50oix95qv) - sodium phosphate, monobasic, monohydrate 40.8 mg - phosphasal ™ tablets are indicated for the treatment of symptoms of irritative voiding. indicated for the relief of local symptoms, such as inflammation, hypermotility, and pain, which accompany lower urinary tract infections. indicated for the relief of urinary tract symptoms caused by diagnostic procedures. hypersensitivity to any of the ingredients is possible. risk benefits should be carefully considered when the following medical problems exist: cardiac disease (especially cardiac arrhythmias, congestive heart failure, coronary heart disease, and mitral stenosis); gastrointestinal tract obstructive disease; glaucoma; myasthenia gravis, acute urinary retention may be precipitated in obstructive uropathy (such as bladder neck obstruction due to prostatic hypertrophy). a dependence on the use of phosphasal ™ tablets has not been reported and due to the nature of its ingredients, abuse of phosphasal ™ tablets is not expected.

İsrail - İngilizce - Ministry of Health

bayer israel ltd - levonorgestrel - intrauterine delivery system - levonorgestrel 13.5 mg - levonorgestrel - contraception for up to 3 years.

İsrail - İngilizce - Ministry of Health

bayer israel ltd - levonorgestrel - intrauterine delivery system - levonorgestrel 13.5 mg - levonorgestrel - contraception for up to 3 years.